Focus Taiwan
Date: 12/17/2020
By: Chang Ming-hsuan and Chung Yu-chen
Taipei, Dec. 17 (CNA) A total of 1 million diabetes drugs manufactured by Taiwan's pharmaceutical company Standard Chem. & Pharm. CO., LTD are being recalled because they are alleged to contain extraneous
Photo courtesy of Food and Drug Administration
The recall involves two types of drugs, Metformin 500 (batch number: TL092117) and Metformin 850 (batch number: TL180260), which were alleged to contain extraneous material made of fiber, the administration said.
Metformin 500 and Metformin 850, which together comprise a 20 percent market share for this type of drug, are frequently used by diabetic patients, said Hung Kuo-teng (洪國登), head of the FDA's Medicinal Products Division, at a telephone interview with reporters on Thursday.
As to what exactly the drugs were found to contain, Hung said the Tainan City-based company is now looking into the case and is required to submit an investigative report at the end of this December. [FULL STORY]
